Related Experiment Videos
Withdrawal from clozapine: the "rebound phenomenon"
R Durst1, A Teitelbaum, G Katz
1Jerusalem Mental Health Center, Kfar Shaul Hospital, Israel.
The Israel Journal of Psychiatry and Related Sciences
|September 3, 1999
Summary
Abruptly stopping clozapine, an atypical antipsychotic, can cause a dangerous rebound phenomenon. This includes psychotic exacerbation and cholinergic rebound, potentially due to cholinergic supersensitivity.
Area of Science:
- Psychopharmacology
- Neuroscience
- Clinical Psychiatry
Background:
- Clozapine is an atypical antipsychotic effective for treatment-resistant schizophrenia.
- It offers advantages over typical neuroleptics, including fewer extrapyramidal side effects.
- Clozapine can induce therapeutic responses in patients refractory to other treatments.
Observation:
- Withdrawal from clozapine can precipitate a "rebound phenomenon."
- This phenomenon presents as psychotic exacerbation and/or cholinergic rebound.
- Case histories illustrate serious deterioration following abrupt clozapine cessation.
Findings:
- The rebound phenomenon suggests a potential underlying mechanism of cholinergic supersensitivity.
- Abrupt clozapine withdrawal can lead to severe clinical deterioration.
- Gradual dose titration may prevent hazardous withdrawal effects.
Implications:
- Clinical guidelines should emphasize cautious clozapine withdrawal protocols.
- Understanding cholinergic supersensitivity is crucial for managing clozapine discontinuation.
- Further research into safe tapering strategies for clozapine is warranted.